Elixiron Immunotherapeutics Stock

Clinical-stage biotech developing precision immunotherapies for neuroinflammatory and autoimmune diseases through innovative mRNA platforms.

Buy

Buy Elixiron Immunotherapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Elixiron Immunotherapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Elixiron Immunotherapeutics is a clinical-stage biotech company focused on developing precision immunotherapies for neuroinflammatory and autoimmune diseases. The company advances therapies such as Enrupatinib for Alzheimer’s disease and Indemakitug for vitiligo, leveraging innovative platforms like mRNA drug development to target the root causes of immune dysfunction.

Founded

2018

Headquarters

Shanghai, China

Buy

Buy Elixiron Immunotherapeutics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Elixiron Immunotherapeutics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Elixiron Immunotherapeutics Management Team

Elixiron Immunotherapeutics people and management

  • Co-Founder, CEO, Board Member
    Hung‑Kai Chen
  • Co-Founder, Chief Scientific Officer
    Cheng‑Lung Ku

Investors

Major Elixiron Immunotherapeutics investors

  • CDIB (MBS) Venture Capital Co., Ltd.

  • DCI Partners

  • Fubon Financial Holdings

  • Hong Tai Electric Industrial

  • Mega International Commercial Bank

  • Pangu Venture Capital

  • Taiwania Capital

Elixiron Immunotherapeutics Valuations & Financials

Gain Insights Into Elixiron Immunotherapeutics Stock Valuation & Share Prices

View real-time NPM data on Elixiron Immunotherapeutics stock including daily Elixiron Immunotherapeutics stock price estimates, valuation history, and historical share price information. Access Elixiron Immunotherapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Elixiron Immunotherapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Elixiron Immunotherapeutics? Get in touch to learn more.

Similar Companies

Explore companies

like Elixiron Immunotherapeutics

  • Podium-Logo

    Podium

    Enterprise Software

    Customer messaging platform enabling companies to connect at critical touch points.

  • Playcast

    Media & Entertainment

    Enables peer-to-peer game streaming that allows users to broadcast gameplay directly while viewers connect through web browsers.

  • Sisu Data

    Enterprise Software

    Uses machine learning to quickly identify key drivers behind business metric changes and uncover actionable insights from complex data.

  • Connecteam

    Enterprise Software

    Streamlines scheduling, communication, and HR tasks for deskless teams through a unified app.

  • Automox

    Enterprise Software

    Automates endpoint patching, configuration enforcement, and vulnerability remediation to secure and simplify IT operations.

  • The Demex Group

    FinTech

    Offers protection which addresses frequent weather-based losses by modeling risk and transferring financial exposure for weather perils.

  • TenSixteen Bio

    Healthcare & Life Sciences

    Leverages human genetics and data science to develop precision medicines for complex diseases using large-scale genomic data.

  • Wherobots

    Enterprise Software

    Cloud platform for spatial analytics and AI that processes geospatial data, delivering insights for industries like real estate and agriculture.

  • Assembled

    Enterprise Software

    Helps customer support teams optimize forecasting, scheduling, and analytics to deliver exceptional customer experiences.

FAQ

Questions?

We have answers

Buy Elixiron Immunotherapeutics Stock

Elixiron Immunotherapeutics stock does not trade on public stock exchanges. Elixiron Immunotherapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Elixiron Immunotherapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Elixiron Immunotherapeutics Stock

Elixiron Immunotherapeutics Stock does not trade on public stock exchanges. In order to sell Elixiron Immunotherapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Elixiron Immunotherapeutics Stock Price

Elixiron Immunotherapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Elixiron Immunotherapeutics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Elixiron Immunotherapeutics Stock Ticker Symbol

There is no ticker symbol for Elixiron Immunotherapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Elixiron Immunotherapeutics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Elixiron Immunotherapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Elixiron Immunotherapeutics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Elixiron Immunotherapeutics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Elixiron Immunotherapeutics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Elixiron Immunotherapeutics IPO

Elixiron Immunotherapeutics is a private company and has not had an IPO. There is currently no Elixiron Immunotherapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Elixiron Immunotherapeutics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.